1: Karanian DA, Karim SL, Wood JT, Williams JS, Lin S, Makriyannis A, Bahr BA. Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. J Pharmacol Exp Ther. 2007 Sep;322(3):1059-66. doi: 10.1124/jpet.107.120147. Epub 2007 Jun 1. PMID: 17545313.
2: Karanian DA, Brown QB, Makriyannis A, Kosten TA, Bahr BA. Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity. J Neurosci. 2005 Aug 24;25(34):7813-20. doi: 10.1523/JNEUROSCI.2347-05.2005. PMID: 16120783; PMCID: PMC6725251.
3: Alapafuja SO, Nikas SP, Bharathan IT, Shukla VG, Nasr ML, Bowman AL, Zvonok N, Li J, Shi X, Engen JR, Makriyannis A. Sulfonyl fluoride inhibitors of fatty acid amide hydrolase. J Med Chem. 2012 Nov 26;55(22):10074-89. doi: 10.1021/jm301205j. Epub 2012 Nov 2. PMID: 23083016; PMCID: PMC3678964.
4: Arizzi MN, Cervone KM, Aberman JE, Betz A, Liu Q, Lin S, Makriyannis A, Salamone JD. Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide. Life Sci. 2004 Jan 9;74(8):1001-11. doi: 10.1016/j.lfs.2003.07.024. PMID: 14672756.
5: Deutsch DG, Lin S, Hill WA, Morse KL, Salehani D, Arreaza G, Omeir RL, Makriyannis A. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem Biophys Res Commun. 1997 Feb 3;231(1):217-21. doi: 10.1006/bbrc.1997.6072. PMID: 9070252.
6: Evagorou A, Anagnostopoulos D, Farmaki E, Siafaka-Kapadai A. Hydrolysis of 2-arachidonoylglycerol in Tetrahymena thermophila. Identification and partial characterization of a Monoacylglycerol Lipase-like enzyme. Eur J Protistol. 2010 Nov;46(4):289-97. doi: 10.1016/j.ejop.2010.06.001. PMID: 20889319.
7: Gkini E, Anagnostopoulos D, Mavri-Vavayianni M, Siafaka-Kapadai A. Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase. Platelets. 2009 Sep;20(6):376-85. doi: 10.1080/09537100903121813. PMID: 19811221.
8: Lastres-Becker I, de Miguel R, De Petrocellis L, Makriyannis A, Di Marzo V, Fernández-Ruiz J. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease. J Neurochem. 2003 Mar;84(5):1097-109. doi: 10.1046/j.1471-4159.2003.01595.x. PMID: 12603833.
9: Rice AS. Cannabinoids and pain. Curr Opin Investig Drugs. 2001 Mar;2(3):399-414. PMID: 11575713.
10: Williams J, Wood J, Pandarinathan L, Karanian DA, Bahr BA, Vouros P, Makriyannis A. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Anal Chem. 2007 Aug 1;79(15):5582-93. doi: 10.1021/ac0624086. Epub 2007 Jun 29. PMID: 17600384.
11: Gifford AN, Bruneus M, Lin S, Goutopoulos A, Makriyannis A, Volkow ND, Gatley SJ. Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). Eur J Pharmacol. 1999 Oct 21;383(1):9-14. doi: 10.1016/s0014-2999(99)00609-3. PMID: 10556675.